- Investor's Business Daily•10 hours ago
Alkermes and Lundbeck are cannibalizing Johnson & Johnson's anti-psychosis sales, Credit Suisse said Monday.
- Market Realist•15 hours ago
Major developments As discussed previously in this series, Johnson & Johnson’s (JNJ) 3Q16 performance was positive across all of its segments. However, the Consumer segment reported a decline in revenue,…...
- Market Realist•16 hours ago
Based on recommendations from 25 broker firms in a Bloomberg survey, Johnson & Johnson (JNJ) received “buy” ratings from ~44% of the firms, and ~56% of the firms rated the company a “hold.” None of the ...
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||113.50 x 200|
|Ask||113.66 x 100|
|Day's Range||113.44 - 114.19|
|52wk Range||94.28 - 126.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||19.94|
|Avg Vol (3m)||6,133,164|
|Dividend & Yield||3.20 (2.82%)|